Skip to the content
Search
Beyond Type 1
Menu
BEYOND TYPE 1
Show sub menu
About
Board of Directors
The Team
Leadership Council
Portfolio
Press
Careers
Contact
Join Us
Diabetes
Type 1 Info
Type 2 Info
Diabetes Management
Newly Diagnosed
Forms Of Diabetes
Autoimmune Diseases
Pregnancy with Type 1 Diabetes
Research
Resources
Stories
Diabetes News
Diabetes Management
Diabetes + Exercise
Mental Health + Diabetes
Food and Diabetes
School Resources
Sex, Drugs + Rock & Roll
Travel + Adventure
Previously Healthy
GetInsulin.org
Newsletter
Programs
Beyond Type 1 App
Beyond Barriers
Beyond Scholars
Community Table
GetInsulin.org
Marathon Team
Snail Mail Club
TuDiabetes
Type 1 Signs
Jesse Was Here
Advocacy
Donate
Search
Tag:
News
First Oral Medication to Treat T1D Approved in Europe
The European Commission (EC) has approved the use of Forxiga (dapagliflozin) as an add-on treatment to insulin therapy for use in in patients with T1D who have a BMI ≥ 27 kg/m2
European Commission Approves Zynquista, First Dual SGLT Inhibitor for T1D
Zynquista is the first dual SGLT1 and SGLT2 inhibitor approved for use in Type 1 diabetes, and the second oral medication approved for use in Type 1 diabetes.
FDA Declines to Approve First Oral Medication for Type 1 Diabetes
The FDA issued a Complete Response Letter for the SGLT-1/2 inhibitor Zynquista (sotagliflozin), declining to approve it for use in T1D at this time.
Making An Invisible Disease Visible: Injecting Myself On Adventure Cyclist Magazine
Annalisa van den Bergh injects herself on the cover of Adventure Cycling, the largest cycling magazine.
Insulin Manufacturers Called on to Explain Skyrocketing Prices
On Tuesday, a group of U.S. Senators led by Patty Murray (D-WA) sent letters to executives at Eli Lilly, Novo Nordisk, and Sanofi demanding information about the rising prices of insulin.
UCSF Team First to Grow Insulin-Producing Cells from Human Stem Cells
Researchers at UCSF have created insulin-producing cells from human stem cells, an incredible breakthrough and benchmark on the road to curing type 1 diabetes. This is the first time scientists have b...
UnitedHealthcare Decision—A Step Backwards for Pump Access
UnitedHealthcare's announcement of a preferred insulin pump for pediatric patients has been denounced by Beyond Type 1 and JDRF.
FreeStyle Libre 2 Approved for Use in U.S.
Those living with type 1 diabetes in the U.S. now have the opportunity to manage their disease utilizing the perks of Abbott’s Freestyle Libre 2.
The Future of Glucagon with Xeris CEO Paul Edick
Beyond Type 1 talks to Paul Edick, President and CEO of Xeris Pharmaceuticals, about their revolutionary glucagon pen.
Government Shutdown Leads to Insulin Rationing
Government workers are increasingly unable to afford basic necessities like food, power, and critical medications like insulin.
Congressman Introduces “Insulin Access For All Act” for Medicaid and Medicare Beneficiaries
Representative Bobby Rush (D-Ill) introduced the Insulin Access For All Act to eliminate the cost-sharing requirement for patients on Medicare and Medicaid
FDA Advisory Vote Split 8-8 on SGLT Inhibitor for T1D
Votes on Zynquista from panel members on the Endocrinologic and Metabolic Drugs Advisory Committee were split 8 to 8. This was the first ever regulatory review for an SGLT inhibitor for use in type 1 ...
National Health Services To Offer Free Glucose Monitors for T1D in the UK
Beginning April 1, people with type 1 diabetes in the UK will have the FreeStyle Libre system completely covered, ending issues with access many are currently facing.
CW Star Unveils Teen Superheroes with Disabilities
Austin Basis details his comic book series "The Kinetix," which features a protagonist who fights crime while maintaining his Type 1 diabetes.
National Health Services to Provide Free CGMs to Pregnant Women with T1D in UK
National Health Services England announced Monday that it would offer continuous glucose monitors to all pregnant women with T1D by 2021.
Posts navigation
←
Newer
Posts
1
…
7
8
9
…
11
Older
Posts
→